MedPath

A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials

Terminated
Conditions
Hepatitis C Virus Infection
Registration Number
NCT02510300
Lead Sponsor
Gilead Sciences
Brief Summary

This Registry will enroll adolescent and pediatric participants who received at least one Gilead Hepatitis C Virus (HCV) direct acting antiviral (DAA) while participating in a Gilead-sponsored chronic hepatitis C clinical trial. The primary objective of this Registry is to determine the long-term safety of anti-HCV regimens in the pediatric population. Secondary objectives of this Registry are to determine whether subsequent detection of HCV RNA in participants who relapse following sustained virologic response (SVR) represents the re-emergence of pre-existing virus, the development of resistance mutations, or whether it is due to re-infection, and to characterize resistance mutations and the persistence of resistance mutations in pediatric participants who did not achieve SVR. Once enrolled, participants will be followed for up to 5 years.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
461
Inclusion Criteria
  • Have previously participated in a Gilead-sponsored chronic hepatitis C study as an adolescent or pediatric participant and received at least one Gilead HCV direct acting antiviral
  • Parent or legal guardian able to provide written informed consent OR individual is able to provide written informed consent prior to any study procedures and willing to comply with study requirements as determined by institutional review board (IRB)/independent ethics committee(IEC)/local requirements and Investigator's discretion.
  • Individual is able to provide written assent, if they have the ability to read and write, as determined by IRB/IEC/local requirements and Investigator's discretion

Key

Exclusion Criteria
  • Individual is currently receiving or plans to initiate a new course of hepatitis C therapy including any investigational drug or device during the course of the follow-up Registry.
  • History of clinically-significant illness or any other major medical disorder that may interfere with the individual's follow-up, assessments or compliance with the protocol.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Growth data as measured by body heightUp to 5 years
Growth data as measured by body weightUp to 5 years
Development as measured by Tanner Pubertal Stage AssessmentUp to 5 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (51)

Nationwide Children's Hospital

🇺🇸

Columbus, Ohio, United States

The Children's Hospital of Philadelphia

🇺🇸

Philadelphia, Pennsylvania, United States

Texas Children's Hospital

🇺🇸

Houston, Texas, United States

Riley Hospital for Children

🇺🇸

Indianapolis, Indiana, United States

Texas Liver Institute

🇺🇸

San Antonio, Texas, United States

Children's Hospital Los Angeles, Div. of Research Immunology/BMT

🇺🇸

Los Angeles, California, United States

Mount Sinai Medical Center

🇺🇸

New York, New York, United States

Scientific-Research Institute of Children's Infections of Federal Medico- Biological Agency

🇷🇺

Saint Petersburg, Russian Federation

Charité Universitätsmedizin Berlin - Campus Virchow-Klinikum

🇩🇪

Berlin, Germany

Boston Children's Hospital

🇺🇸

Boston, Massachusetts, United States

Children's Healthcare of Atlanta at Egleston

🇺🇸

Atlanta, Georgia, United States

Saint Louis University School of Medicine

🇺🇸

Saint Louis, Missouri, United States

Ospedale Casa Sollievo della Sofferenza

🇮🇹

San Giovanni Rotondo, Foggia, Italy

Azienda Ospedaliero Universitaria - Ospedale Pediatrico Meyer

🇮🇹

Firenze, Italy

Ltd Medical Company "Hepatolog"

🇷🇺

Tolyatti, Russian Federation

Johns Hopkins University School of Medicine

🇺🇸

Baltimore, Maryland, United States

West Virginia University Children's Hospital

🇺🇸

Morgantown, West Virginia, United States

Children's National Medical Center

🇺🇸

Washington, District of Columbia, United States

The Children's Hospital at Westmead

🇦🇺

Westmead, New South Wales, Australia

Children's Medical Center Dallas

🇺🇸

Dallas, Texas, United States

Seattle Children's Hospital

🇺🇸

Seattle, Washington, United States

Cook Children's Health Care System

🇺🇸

Fort Worth, Texas, United States

Cliniques Universitaires Saint- LUC UCL

🇧🇪

Brussels, Belgium

Helios Klinikum Wuppertal

🇩🇪

Wuppertal, Germany

Polo Universitario - L'Azienda Ospedaliera Luigi Sacco

🇮🇹

Milano, Italy

Azienda Ospedaliero-Universitaria di Padova

🇮🇹

Padova, Italy

Auckland Clinical Studies

🇳🇿

Auckland, New Zealand

Cincinnati Children's Hospital Medical Center

🇺🇸

Cincinnati, Ohio, United States

Wojewódzki Szpital Obserwacyjno-Zakaźny im. Tadeusza Browicza, Klinika Chorób Zakaźnych i Hepatologii Wieku Rozwojowego

🇵🇱

Bydgoszcz, Poland

The Royal Children's Hospital

🇦🇺

Parkville, Victoria, Australia

MED. POLONIA Sp. z.o.o.

🇵🇱

Poznan, Poland

Policlinico Sant'Orsola Malpighi

🇮🇹

Bologna, Italy

Azienda Ospedaliero-Universitaria Citta della Salute e della Scienza di Torino

🇮🇹

Torino, Italy

Azienda Ospedaliera Universitaria Federico II

🇮🇹

Napoli, Italy

Birmingham Childrens Hospital NHS Trust

🇬🇧

Birmingham, United Kingdom

King's College Hospital

🇬🇧

London, United Kingdom

John Hunter Children's Hospital (JHCH)

🇦🇺

New Lambton Heights, New South Wales, Australia

Federal Budget Institution of Science-Central Scientific and Research Institute of Epidemiology

🇷🇺

Moscow, Russian Federation

Federal Government Institution "Republican Clinical Infectious Hospital"

🇷🇺

Saint-Petersburg, Russian Federation

Royal Hospital for Sick Children Glasgow

🇬🇧

Glasgow, United Kingdom

Leeds Teaching Hospitals NHS Trust

🇬🇧

Leeds, United Kingdom

University of California San Francisco

🇺🇸

San Francisco, California, United States

Monroe Carell Jr. Children's Hospital at Vanderbilt

🇺🇸

Nashville, Tennessee, United States

Children's Hospital of Colorado

🇺🇸

Aurora, Colorado, United States

UNC Pediatrics/NC Children's Hospital

🇺🇸

Chapel Hill, North Carolina, United States

Phoenix Children's Hospital

🇺🇸

Phoenix, Arizona, United States

University of Florida

🇺🇸

Gainesville, Florida, United States

AdventHealth Orlando

🇺🇸

Orlando, Florida, United States

Children's Mercy Hospital and Clinics

🇺🇸

Kansas City, Missouri, United States

University of Nebraska Medical Center

🇺🇸

Omaha, Nebraska, United States

University of Louisville School of Medicine

🇺🇸

Louisville, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath